US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Faeth Therapeutics

34.45

+2.457.66%

Volume:328.57K

Turnover:11.14M

Market Cap:888.08M

PE:-0.24

High:35.05

Open:32.80

Low:30.30

Close:32.00

52wk High:37.90

52wk Low:7.45

Shares:25.78M

Float Shares:811.70K

Volume Ratio:1.07

T/O Rate:40.48%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-141.6499

EPS(LYR):-16.7239

ROE:-195.26%

ROA:-20.79%

PB:5.13

PE(LYR):-2.06

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Faeth Therapeutics

Exchange:

NASDAQ

Establishment Date:

1999

Employees:

29

Office Location:

1405 Research Boulevard,Suite 125,Rockville,Maryland,United States

Website:

http://www.faeththerapeutics.com

Zip Code:

20850

Phone:

Fax:

- -

Introduction:

Sensei Biotherapeutics, Inc., an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. Its Tumor Microenvironment Activated Biologics platform is designed to unleash the anti-tumor potential of T cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company's pipeline includes SNS-101, SNS-103, and SNS-102, monoclonal antibodies, which are in early development stages for the treatment of solid tumors. It has a collaboration with The University of Washington to conduct preclinical studies for its SNS-101 program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.

Directors

Name

Position

Bob Holmen

Director

Karen Vousden

Director

Kristian Humer

Director

Phillip B. Donenberg

Director

Saira Ramasastry

Director

Stephen M. Hahn

Director

Thomas Ricks

Director

Shareholders

Name

Position

Anand Parikh

Chief Operating Officer

Josiah Craver

Principal Financial and Accounting Officer and Senior Vice President of Finance

Brian Stephenson

Head of Operations and Finance

Christopher W. Gerry

General Counsel and President

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/FTH/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","market":"US","secType":"STK","nameCN":"Faeth Therapeutics","latestPrice":34.45,"timestamp":1787598794166,"preClose":32,"halted":0,"volume":328567,"delay":0,"changeRate":0.07656250000000009,"floatShares":811700,"shares":25778800,"eps":-141.6499,"marketStatus":"Trading","change":2.45,"latestTime":"08-24 15:13:21 EDT","open":32.8,"high":35.05,"low":30.3,"amount":11143014.666660002,"amplitude":0.148437,"askPrice":34.45,"askSize":140,"bidPrice":34.32,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-141.6499,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"listingDate":1612414800000,"exchange":"NASDAQ","adjPreClose":32,"preHourTrading":{"tag":"盘前","latestPrice":32,"preClose":32,"latestTime":"07:02 EDT","volume":5,"amount":160,"timestamp":1787569349699,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":32,"preClose":32,"latestTime":"19:30 EDT","volume":1722,"amount":55104,"timestamp":1787355006301,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.067217},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","floatShares":811700,"roa":"-20.79%","roe":"-195.26%","lyrEps":-16.72388,"volumeRatio":1.067217,"shares":25778800,"dividePrice":0,"high":35.05,"amplitude":0.148437,"preClose":32,"low":30.3,"week52Low":7.45,"pbRate":"5.13","week52High":37.9,"institutionHeld":0,"latestPrice":34.45,"committee":-0.166667,"eps":-141.6499,"divideRate":0,"volume":328567,"delay":0,"ttmEps":-141.6499,"open":32.8,"prevYearClose":10.67,"prevWeekClose":32,"prevMonthClose":27.24,"prevQuarterClose":25,"fiveDayClose":32.77,"twentyDayClose":29.24,"sixtyDayClose":17.59},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"FTH","fiscalQuarterEnding":"2026/06","expectedEps":-1.1,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"pre","actualEps":-2.84},{"market":"US","date":"2026-05-15","symbol":"FTH","fiscalQuarterEnding":"2026/03","expectedEps":-0.62,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-131.45},{"market":"US","date":"2026-03-30","symbol":"FTH","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"pre","actualEps":-3.74},{"market":"US","date":"2025-11-14","symbol":"FTH","fiscalQuarterEnding":"2025/09","expectedEps":-4.11,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-3.62},{"market":"US","date":"2025-08-05","symbol":"FTH","fiscalQuarterEnding":"2025/06","expectedEps":-6.2,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-3.91}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4167,"buy":0.5833,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5833,"analysts":12,"updateTime":1785902400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FTH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FTH","date":"2026-08-21","current":-0.225909,"percent":0.204545,"low":-5.053534,"twenty":-4.248589,"median":-3.806921,"eighty":-3.244483,"high":-0.105707,"avg":-3.520013,"sd":1.147061,"marketCap":829477642},"quantilePoints":[{"date":"2026-06-18","current":-0.12113,"twenty":-0.118045,"median":-0.113419,"eighty":-0.108792,"marketCap":22343317},{"date":"2026-06-26","current":-3.447751,"twenty":-3.41449,"median":-0.168709,"eighty":-0.122832,"marketCap":635961861},{"date":"2026-07-02","current":-3.306599,"twenty":-3.429583,"median":-3.245107,"eighty":-0.129642,"marketCap":609925319},{"date":"2026-07-10","current":-4.547622,"twenty":-3.49387,"median":-3.330357,"eighty":-0.168709,"marketCap":838840655},{"date":"2026-07-17","current":-3.62524,"twenty":-4.398084,"median":-3.429583,"eighty":-3.196193,"marketCap":668700878},{"date":"2026-07-24","current":-3.879594,"twenty":-4.005373,"median":-3.554664,"eighty":-3.20318,"marketCap":715618211},{"date":"2026-07-31","current":-4.027734,"twenty":-4.074133,"median":-3.637119,"eighty":-3.236722,"marketCap":742943690},{"date":"2026-08-07","current":-3.227486,"twenty":-4.048697,"median":-3.62524,"eighty":-3.239088,"marketCap":631063897},{"date":"2026-08-14","current":-3.773087,"twenty":-4.030809,"median":-3.711043,"eighty":-3.239088,"marketCap":737744133},{"date":"2026-08-21","current":-4.242245,"twenty":-4.248589,"median":-3.806921,"eighty":-3.244483,"marketCap":829477642}],"updateTime":1787559237427},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":732397,"yearFounded":1999,"employeeNum":29,"address":"1405 Research Boulevard,Suite 125,Rockville,Maryland,United States","zipCode":"20850","officePhone":"240 243 8000","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.faeththerapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0105},{"period":"1month","weight":0.1165},{"period":"3month","weight":0.7988},{"period":"6month","weight":-0.0448},{"period":"1year","weight":3.2406},{"period":"ytd","weight":1.9991}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Sensei Biotherapeutics, Inc., an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. Its Tumor Microenvironment Activated Biologics platform is designed to unleash the anti-tumor potential of T cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company's pipeline includes SNS-101, SNS-103, and SNS-102, monoclonal antibodies, which are in early development stages for the treatment of solid tumors. It has a collaboration with The University of Washington to conduct preclinical studies for its SNS-101 program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.040355},{"month":2,"riseRate":0.6,"avgChangeRate":0.423412},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.06831},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.097622},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.09801},{"month":6,"riseRate":0.5,"avgChangeRate":0.03411},{"month":7,"riseRate":0.5,"avgChangeRate":-0.036531},{"month":8,"riseRate":0.5,"avgChangeRate":0.06159},{"month":9,"riseRate":0.2,"avgChangeRate":-0.058884},{"month":10,"riseRate":0,"avgChangeRate":-0.117074},{"month":11,"riseRate":0.4,"avgChangeRate":-0.031651},{"month":12,"riseRate":0.4,"avgChangeRate":0.005246}],"exchange":"NASDAQ","name":"Faeth Therapeutics","nameEN":"Faeth Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"FTH\",market:\"US\",,,undefined,":{"directors":[{"name":"Bob Holmen","position":"Director"},{"name":"Karen Vousden","position":"Director"},{"name":"Kristian Humer","position":"Director"},{"name":"Phillip B. Donenberg","position":"Director"},{"name":"Saira Ramasastry","position":"Director"},{"name":"Stephen M. Hahn","position":"Director"},{"name":"Thomas Ricks","position":"Director"}],"executives":[{"name":"Anand Parikh","position":"Chief Operating Officer"},{"name":"Josiah Craver","position":"Principal Financial and Accounting Officer and Senior Vice President of Finance"},{"name":"Brian Stephenson","position":"Head of Operations and Finance"},{"name":"Christopher W. Gerry","position":"General Counsel and President"}]}}}